BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 28483313)

  • 1. Immediate Hypersensitivity Reaction to Chemotherapeutic Agents.
    Giavina-Bianchi P; Patil SU; Banerji A
    J Allergy Clin Immunol Pract; 2017; 5(3):593-599. PubMed ID: 28483313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid desensitization of hypersensitivity reactions to chemotherapy agents.
    Castells M
    Curr Drug Saf; 2006 Aug; 1(3):243-51. PubMed ID: 18690934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Basophil Activation Test is a Relevant Biomarker of the Outcome of Rapid Desensitization in Platinum Compounds-Allergy.
    Giavina-Bianchi P; Galvão VR; Picard M; Caiado J; Castells MC
    J Allergy Clin Immunol Pract; 2017; 5(3):728-736. PubMed ID: 28034549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platinum Chemotherapy Hypersensitivity: Prevalence and Management.
    Otani IM; Wong J; Banerji A
    Immunol Allergy Clin North Am; 2017 Nov; 37(4):663-677. PubMed ID: 28965633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anaphylaxis to chemotherapy and monoclonal antibodies.
    Castells MC
    Immunol Allergy Clin North Am; 2015 May; 35(2):335-48. PubMed ID: 25841555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Usefulness of Omalizumab in Rapid Drug Desensitization in Patients With Severe Anaphylaxis Induced by Carboplatin: Open Questions.
    Sánchez-Morillas L; Casado Herráez A; Rubio-Perez M; Robledo Echarren T; González Gutiérrez ML; Cimarra M; Vázquez Cortés S; Cerecedo I; Fernández-Rivas M
    J Investig Allergol Clin Immunol; 2020; 30(4):298-300. PubMed ID: 32101175
    [No Abstract]   [Full Text] [Related]  

  • 7. Hypersensitivity Reaction and Rapid Drug Desensitization with Chemotherapeutics: A Tertiary Reference Center Experiences.
    Bulut İ; Yegin Katran Z
    Int Arch Allergy Immunol; 2023; 184(9):849-855. PubMed ID: 37442106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Desensitization to chemotherapeutic agents.
    Lieberman P; Castells M
    J Allergy Clin Immunol Pract; 2014; 2(1):116-7. PubMed ID: 24565784
    [No Abstract]   [Full Text] [Related]  

  • 9. Desensitization for Drug Hypersensitivity to Chemotherapy and Monoclonal Antibodies.
    Bonamichi-Santos R; Castells M
    Curr Pharm Des; 2016; 22(45):6870-6880. PubMed ID: 27784245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Review of hypersensitivity reactions to antineoplastic agents.
    Cortijo-Cascajares S; Jiménez-Cerezo MJ; Herreros de Tejada A
    Farm Hosp; 2012; 36(3):148-58. PubMed ID: 22484106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platinum hypersensitivity and desensitization.
    Miyamoto S; Okada R; Ando K
    Jpn J Clin Oncol; 2015 Sep; 45(9):795-804. PubMed ID: 26056327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of Hypersensitivity Reactions to Taxanes.
    Picard M
    Immunol Allergy Clin North Am; 2017 Nov; 37(4):679-693. PubMed ID: 28965634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immediate hypersensitivity reactions to antineoplastic agents - A practical guide for the oncologist.
    Seghers S; Teuwen LA; Beyens M; De Blick D; Sabato V; Ebo DG; Prenen H
    Cancer Treat Rev; 2023 May; 116():102559. PubMed ID: 37084565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnoses and Management of Drug Hypersensitivity and Anaphylaxis in Cancer and Chronic Inflammatory Diseases: Reactions to Taxanes and Monoclonal Antibodies.
    Bonamichi-Santos R; Castells M
    Clin Rev Allergy Immunol; 2018 Jun; 54(3):375-385. PubMed ID: 27277133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Desensitization for hypersensitivity reactions to medications.
    del Carmen Sancho M; Breslow R; Sloane D; Castells M
    Chem Immunol Allergy; 2012; 97():217-33. PubMed ID: 22613865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypersensitivity reactions to chemotherapy: outcomes and safety of rapid desensitization in 413 cases.
    Castells MC; Tennant NM; Sloane DE; Hsu FI; Barrett NA; Hong DI; Laidlaw TM; Legere HJ; Nallamshetty SN; Palis RI; Rao JJ; Berlin ST; Campos SM; Matulonis UA
    J Allergy Clin Immunol; 2008 Sep; 122(3):574-80. PubMed ID: 18502492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sequential rapid oral desensitization to rifampin and moxifloxacin for the treatment of active mycobacterium tuberculosis.
    Benken ST; Nyenhuis SM; Dunne S
    J Allergy Clin Immunol Pract; 2017; 5(1):195-197. PubMed ID: 27838324
    [No Abstract]   [Full Text] [Related]  

  • 18. Hypersensitivity to biological agents-updated diagnosis, management, and treatment.
    Galvão VR; Castells MC
    J Allergy Clin Immunol Pract; 2015; 3(2):175-85; quiz 186. PubMed ID: 25754718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Desensitization for Allergic Reactions to Chemotherapy.
    Hong DIC
    Yonsei Med J; 2019 Feb; 60(2):119-125. PubMed ID: 30666832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug desensitization in the management of hypersensitivity reactions to monoclonal antibodies and chemotherapy.
    Mezzano V; Giavina-Bianchi P; Picard M; Caiado J; Castells M
    BioDrugs; 2014 Apr; 28(2):133-44. PubMed ID: 23990250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.